On April 30, 2024, Jeffrey Melucci, Chief Business & Transformation Officer, sold 13,714 shares of Kimberly-Clark Corp (NYSE:KMB) as reported in the SEC Filing. The transaction occurred with shares priced at $135.53, totaling approximately $1,859,188.42. Warning! GuruFocus has detected 6 Warning Sign with KMB. Kimberly-Clark Corp (NYSE:KMB), a global leader in personal care products, manufactures and markets a wide range of products primarily for household use. Its portfolio includes well-known brands such as Huggies, Kleenex, and Scott, serving customers worldwide. Over the past year, Jeffrey Melucci has sold a total of 27,527 shares of the company and has not made any purchases. This recent sale is part of a broader trend within the company, where there have been 13 insider sells and only 1 insider buy over the same period. Insider Sale: Chief Business & Transformation Officer Jeffrey Melucci Sells 13,714 Shares of Kimberly-Clark Corp (KMB) As of the latest transaction, Kimberly-Clark Corp (NYSE:KMB) holds a market cap of $45.97 billion. The stock's price-earnings ratio stands at 25.10, which is above both the industry median of 18.645 and the company's historical median. The GF Value of Kimberly-Clark Corp is calculated at $136.17, suggesting that the stock is Fairly Valued at a price-to-GF-Value ratio of 1. This valuation is supported by historical trading multiples, an adjustment factor based on past performance, and future business performance estimates. Insider Sale: Chief Business & Transformation Officer Jeffrey Melucci Sells 13,714 Shares of Kimberly-Clark Corp (KMB) This insider sale might interest investors tracking insider behaviors as an indicator of corporate confidence and market movements. For more detailed insights and further updates, investors are encouraged to follow the links provided and monitor Kimberly-Clark Corp's filings and market performance. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Insider Sale: Chief Business & Transformation Officer Jeffrey Melucci Sells 13,714 Shares ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...